Tscan Therapeutics

TCRX

NASDAQHealth Care

Income Statement

Total Revenue$2.82M

Gross Profit$2.82M

Operating Income$-134.82M

EBITDA$-119.74M

EBIT$-123.85M

Pre-tax Income$-142.6M

Net Income$-127.5M

Cash Equivalent$178.65M

Total Debt$92.64M

Book Value$212.06M

Book Value Per Share4.10

Return on Equity (ROE)-52.91%

Return on Assets (ROA)-34.36%

Return on Invested Capital (ROI)-46.70%

Net Profit Margin-4527.66%

Current Ratio8.14

Quick Ratio8.07

Long-Term Debt / Equity0.13